{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:07:15Z","timestamp":1760980035579},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1985,8,1]],"date-time":"1985-08-01T00:00:00Z","timestamp":491702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch. Pharmacol."],"published-print":{"date-parts":[[1985,8]]},"DOI":"10.1007\/bf00499901","type":"journal-article","created":{"date-parts":[[2004,11,16]],"date-time":"2004-11-16T22:41:25Z","timestamp":1100644885000},"page":"97-104","source":"Crossref","is-referenced-by-count":71,"title":["Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. pharmacological and regional specificity"],"prefix":"10.1007","volume":"330","author":[{"given":"J.","family":"Arnt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0014-2999(84)90267-X","volume":"102","author":"J Arnt","year":"1984","unstructured":"Arnt J, Hyttel J (1984) Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions. Eur J Pharmacol 102:349?354","journal-title":"Eur J Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(80)91016-1","volume":"192","author":"CJ Carter","year":"1980","unstructured":"Carter CJ, Pycock CJ (1980) Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat. Brain Res 192:163?176","journal-title":"Brain Res"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0024-3205(84)90607-6","volume":"34","author":"AV Christensen","year":"1984","unstructured":"Christensen AV, Arnt J, Hyttel J, Larsen JJ, Svendsen O (1984) Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics. Life Sci 34:1529?1540","journal-title":"Life Sci"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0024-3205(80)90217-9","volume":"27","author":"AR Cools","year":"1980","unstructured":"Cools AR, vanRossum JM (1980) Multiple receptors for brain dopamine in behaviour regulation: Concept of dopamine-E and dopamine-I receptors. Life Sci 27:1237?1253","journal-title":"Life Sci"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.2042-7158.1979.tb13518.x","volume":"31","author":"B Costall","year":"1979","unstructured":"Costall B, Fortune DH, Naylor FJ (1979) Neuropharmacological studies on the neuroleptic potential of domperidone (R33812). J Pharm Pharmacol 31:344?347","journal-title":"J Pharm Pharmacol"},{"key":"CR6","first-page":"3","volume":"1","author":"B Costall","year":"1980","unstructured":"Costall B, Naylor RJ (1980) Assessment of the test procedures used to analyse neuroleptic action. Rev. Pur Applied Pharmacological Sci 1:3?83","journal-title":"Rev. Pur Applied Pharmacological Sci"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0028-3908(80)90036-2","volume":"19","author":"B Costall","year":"1980","unstructured":"Costall B, De Souza CX, Naylor RJ (1980) Topographical analysis of the actions of 2-(N,N-dipropyl)amino-5,6-dihydroxytetralin to cause biting behaviour and locomotor hyperactivity form the striatum of the guinea-pig. Neuropharmacology 19:623?631","journal-title":"Neuropharmacology"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(83)90531-9","volume":"96","author":"B Costall","year":"1983","unstructured":"Costall B, Kelly ME, Naylor RJ (1983) The production of asymmetry and circling behaviour following unilateral, intrastriatal administration of neuropleptic agents: A comparison of abilities to antagonise striatal function. Eur J Pharmacol 96:79?86","journal-title":"Eur J Pharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00498452","volume":"307","author":"A Delini-Stula","year":"1979","unstructured":"Delini-Stula A, Bauman P, B\u00fcch O (1979) Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre- and postsynaptic central noradrenergic receptor selectivity of ?-adrenolytic drugs. Naunyn-Schmiedeberg's Arch Pharmacol 307:115?122","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.2042-7158.1983.tb02957.x","volume":"35","author":"S Fleminger","year":"1983","unstructured":"Fleminger S, Van de Waterbeemd H, Rupniak NMJ, Reavill C, Testa B, Jenner P, Marsden CD (1983) Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the rat. J Pharm Pharmacol 35:363?368","journal-title":"J Pharm Pharmacol"},{"key":"CR11","unstructured":"Fog R (1972) On stereotypy and catalepsy: Studies on the effect of amphetamines and neuroleptics in rats Acta Neurol Scand 48, suppl. 50"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1254\/jjp.27.397","volume":"27","author":"F Honda","year":"1977","unstructured":"Honda F, Satoh Y, Shimomura K: Satoh H, Noguchi H, Uchida S, Kato R (1977) Dopamine receptor blocking activity of sulpiride in the central nervous system. Jpn J Pharmacol 27:397?411","journal-title":"Jpn J Pharmacol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00427604","volume":"67","author":"J Hyttel","year":"1980","unstructured":"Hyttel J (1980) Further evidence that 3H-cis(Z)-flupenthixol binds to the adenylate cyclase-associated dopamine receptor (D-1) in rat corpus striatum. Psychopharmacology 67:107?109","journal-title":"Psychopharmacology"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(83)90381-3","volume":"91","author":"J Hyttel","year":"1983","unstructured":"Hyttel J (1983) SCH 23390 ? the first selective dopamine D-1 antagonist. Eur J Pharmacol 91:153?154","journal-title":"Eur J Pharmacol"},{"key":"CR15","first-page":"143","volume-title":"CRC Handbook of stereoisomers: Drugs in psychopharmacology","author":"J Hyttel","year":"1984","unstructured":"Hyttel J, Arnt J, B\u00f8ges\u00f8 KP (1984) Antipsychotic drugs: Configurational stereoisomers. In: Smith DF (ed) CRC Handbook of stereoisomers: Drugs in psychopharmacology. CRC Press Inc, Forida, p 143"},{"key":"CR16","first-page":"462","volume":"226","author":"LC Iorio","year":"1983","unstructured":"Iorio LC, Barnett A, Leitz FH, Houser VP, Korduba CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226:462?468","journal-title":"J Pharmacol Exp Ther"},{"key":"CR17","first-page":"209","volume-title":"Advances in biochemical psychopharmacology, vol 16","author":"SD Iversen","year":"1977","unstructured":"Iversen SD, Koob GF (1977) Behavioural implications of dopaminergic neurones in the mesolimbic system. In: Costa E, Gessa GL (eds) Advances in biochemical psychopharmacology, vol 16. Raven Press, New York, pp 209?214"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0149-7634(83)90017-9","volume":"7","author":"JN Joyce","year":"1983","unstructured":"Joyce JN (1983) Multiple dopamine receptors and behaviour. Neuroscience Biobehavioral Reviews 7:227?256","journal-title":"Neuroscience Biobehavioral Reviews"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","volume":"277","author":"JW Kebabian","year":"1979","unstructured":"Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93?96","journal-title":"Nature"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0006-8993(75)90233-4","volume":"94","author":"PH Kelly","year":"1975","unstructured":"Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507?522","journal-title":"Brain Res"},{"key":"CR21","volume-title":"The rat brain","author":"JFR K\u00f6nig","year":"1963","unstructured":"K\u00f6nig JFR, Klippel RA (1963) The rat brain. Williams and Wilkins, Baltimore"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0024-3205(81)90747-5","volume":"28","author":"JE Leysen","year":"1981","unstructured":"Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PAJ (1981) Receptor binding profile of R 41468, a novel antagonist at 5-HT2 receptors. Life Sci 28:1015?1022","journal-title":"Life Sci"},{"key":"CR23","first-page":"467","volume":"217","author":"R Massingham","year":"1981","unstructured":"Massingham R, Dubocovich ML, Shepperson NB, Langer SZ (1981) In vivo selectivity of prazosin but not of WB 4101 for postsynaptic alpha-1 adrenoceptors. J Pharmacol Exp Ther 217:467?474","journal-title":"J Pharmacol Exp Ther"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/0024-3205(79)90096-1","volume":"24","author":"CJE Niemegeers","year":"1979","unstructured":"Niemegeers CJE, Janssen PAJ (1979) A systematic study of the pharmacological activities of dopamine antagonists. Life Sci 24:2201?2216","journal-title":"Life Sci"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1176\/ajp.137.12.1518","volume":"137","author":"SJ Peroutka","year":"1980","unstructured":"Peroutka SJ, Snyder SH (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, ]ga-adrenergic, and histamine receptors to clinical potency. Am J Psychiatr 137:1518?1522","journal-title":"Am J Psychiatr"},{"key":"CR26","first-page":"655","volume":"76","author":"G Perrault","year":"1981","unstructured":"Perrault G, Margarit J, Laville C (1981) Propriet\u00e9s antidopaminergiques centrales compar\u00e9es due v\u00e9ralipride et du sulpiride. Rev Fr Gyn\u00e9col Obst\u00e9t 76:655?660","journal-title":"Rev Fr Gyn\u00e9col Obst\u00e9t"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0028-3908(84)90219-3","volume":"23","author":"F Petty","year":"1984","unstructured":"Petty F, Mott J, Sherman AD (1984) Potentical locus and mechanism of blockade of conditioned avoidance responding by neuroleptics. Neuropharmacology 23:73?78","journal-title":"Neuropharmacology"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00426211","volume":"45","author":"AJJ Pijnenburg","year":"1975","unstructured":"Pijnenburg AJJ, Honig WMM, Van Rossum JM (1975) Antagonism of apomorphine- and d-amphetamine-induced stereotyped behaviour by injection of low doses of haloperidol into the caudate nucleus and the nucleus accumbens. Psychopharmacologia (Berl) 45:65?71","journal-title":"Psychopharmacologia (Berl)"},{"key":"CR29","first-page":"215","volume-title":"The GABA-receptors","author":"J Scheel-Kr\u00fcger","year":"1983","unstructured":"Scheel-Kr\u00fcger J (1983) The GABA receptor and animal behavior. Evidence that GABA transmits and mediates dopaminergic functions in the basal ganglia and the limbic system. In: Enna SJ (ed) The GABA-receptors. The Humana Press, Clifton, New Jersey, p 215"},{"key":"CR30","volume-title":"Dyskinesia ? research and treatment","author":"J Scheel-Kr\u00fcger","year":"1985","unstructured":"Scheel-Kr\u00fcger J, Arnt J (1985) New aspects on the role of dopamine, acetylcholine and GABA for the development of tardive dyskinesia. In: Casey D, Chase TN, Christensen AV, Gerlach J (eds) Dyskinesia ? research and treatment. Springer, Berlin Heidelberg New York"},{"key":"CR31","first-page":"229","volume":"32","author":"P Seeman","year":"1981","unstructured":"Seeman P (1981) Brain dopamine receptors. Pharmacological Reviews 32:229?313","journal-title":"Pharmacological Reviews"},{"key":"CR32","volume-title":"Nonparametric statistics for the behavioral sciences","author":"S Siegel","year":"1956","unstructured":"Siegel S (1956) Nonparametric statistics for the behavioral sciences. McGraw-Hill, New York"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1254\/jjp.33.749","volume":"33","author":"M Terai","year":"1983","unstructured":"Terai M, Usuda S, Kuroiwa I, Noshiro O, Maeno H (1983) Selective binding YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors. Jpn J Pharmacol 33:749?755","journal-title":"Jpn J Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00499901.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00499901\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00499901","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T14:15:10Z","timestamp":1554387310000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00499901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,8]]}},"alternative-id":["BF00499901"],"URL":"https:\/\/doi.org\/10.1007\/bf00499901","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,8]]}}}